The race to make COVID antibody therapies cheaper and more potent
Injections of antibodies might prevent mild COVID-19 from becoming severe, but the treatments are expensive and difficult to make.
Eric Topol
128d ago
There are 10 different monoclonal antibodies to #SARSCoV2 in clinical trials. But we really need nanobodies, given by SQ self-injection or inhalation, that are cheap, more scalable, and practical. There are precedents for these
nature.com/articles/d4158…
by @heidiledford @NatureNews
14
“What you really want is something that is so amazingly potent that you need barely any" #mAbs #COVID19